Lipopolysaccharide induces H1 receptor expression and enhances histamine responsiveness in human coronary artery endothelial cells

Immunology

Volumn 132, Issue 4, 2011, Pages 578-588

  Raveendran, Vineesh V ^a   Tan, Xiaoyu ^a   Sweeney, Matthew E ^a   Levant, Beth ^a   Slusser, Joyce ^b   Stechschulte, Daniel J ^a   Dileepan, Kottarappat N ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Endothelial cells; Endotoxin lipopolysaccharide; H1 receptor; Inflammation; Innate immunity

Indexed keywords

HISTAMINE; HISTAMINE H1 RECEPTOR; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; MEPYRAMINE; MESSENGER RNA; PROSTACYCLIN; PROSTAGLANDIN G2; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4;

ARTICLE; CONCENTRATION (PARAMETERS); CORONARY ARTERY; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN SYNTHESIS; WESTERN BLOTTING;

BLOTTING, WESTERN; CELLS, CULTURED; CORONARY VESSELS; DINOPROSTONE; DRUG SYNERGISM; ENDOTHELIAL CELLS; EPOPROSTENOL; FLOW CYTOMETRY; GENE EXPRESSION; HISTAMINE; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; PYRILAMINE; RADIOLIGAND ASSAY; RECEPTORS, HISTAMINE H1; RECEPTORS, HISTAMINE H2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; SULFONAMIDES; TOLL-LIKE RECEPTOR 4; TRITIUM;

EID: 79952536118     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03403.x     Document Type: Article

References (53)

1. Ogawa Y, Grant JA. Mediators of anaphylaxis. Immunol Allergy Clin North Am 2007; 27:249-60.
2. Alving K. Airways vasodilatation in the immediate allergic reaction. Involvement of inflammatory mediators and sensory nerves. Acta Physiol Scand Suppl 1991; 597:1-64.
3. Elenkov IJ, Webster E, Papanicolaou DA, Fleisher TA, Chrousos GP, Wilder RL. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol 1998; 161:2586-93.
4. Dileepan KN, Lorsbach RB, Stechschulte DJ. Mast cell granules inhibit macrophage-mediated lysis of mastocytoma cells (P815) and nitric oxide production. J Leukoc Biol 1993; 53:446-53.
5. Chaldakov GN, Fiore M, Stankulov IS et al. NGF, BDNF, leptin, and mast cells in human coronary atherosclerosis and metabolic syndrome. Arch Physiol Biochem 2001; 109:357-60.
6. Sakata Y, Komamura K, Hirayama A, Nanto S, Kitakaze M, Hori M, Kodama K. Elevation of the plasma histamine concentration in the coronary circulation in patients with variant angina. Am J Cardiol 1996; 77:1121-6.
7. Delneste Y, Lassalle P, Jeannin P, Joseph M, Tonnel AB, Gosset P. Histamine induces IL-6 production by human endothelial cells. Clin Exp Immunol 1994; 98:344-9.
8. Jeannin P, Delneste Y, Gosset P, Molet S, Lassalle P, Hamid Q, Tsicopoulos A, Tonnel AB. Histamine induces interleukin-8 secretion by endothelial cells. Blood 1994; 84:2229-33.
9. Li Y, Chi L, Stechschulte DJ, Dileepan KN. Histamine-induced production of interleukin-6 and interleukin-8 by human coronary artery endothelial cells is enhanced by endotoxin and tumor necrosis factor-alpha. Microvasc Res 2001; 61:253-62.
10. Hough LB. Genomics meets histamine receptors: new subtypes, new receptors. Mol Pharmacol 2001; 59:415-9.
11. Terada N, Hamano N, Maesako KI, Hiruma K, Hohki G, Suzuki K, Ishikawa K, Konno A. Diesel exhaust particulates upregulate histamine receptor mRNA and increase histamine-induced IL-8 and GM-CSF production in nasal epithelial cells and endothelial cells. Clin Exp Allergy 1999; 29:52-9.
12. Roumestan C, Henriquet C, Gougat C, Michel A, Bichon F, Portet K, Jaffuel D, Mathieu M. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms. Clin Exp Allergy 2008; 38:947-56.
13. Kohka H, Nishibori M, Iwagaki H et al. Histamine is a potent inducer of IL-18 and IFN-gamma in human peripheral blood mononuclear cells. J Immunol 2000; 164:6640-6.
14. Endo Y, Kumagai K. Induction by interleukin-1, tumor necrosis factor and lipopolysaccharides of histidine decarboxylase in the stomach and prolonged accumulation of gastric acid. Br J Pharmacol 1998; 125:842-8.
15. Le S, Finn JP, Larijani ME, Marino MJ, Schaffhauser H. Detection of low level histamine H3 receptor occupancy by autoradiography. J Neurosci Methods 2009; 185:70-5.
16. Arrang JM, Morisset S, Gbahou F. Constitutive activity of the histamine H3 receptor. Trends Pharmacol Sci 2007; 28:350-7.
17. Nakamura T, Itadani H, Hidaka Y, Ohta M, Tanaka K. Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun 2000; 279:615-20.
18. Morse KL, Behan J, Laz TM et al. Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther 2001; 296:1058-66.
19. Grayston JT, Kuo CC, Campbell LA, Benditt EP. Chlamydia pneumoniae, strain TWAR and atherosclerosis. Eur Heart J 1993; 14(Suppl. K):66-71.
20. Shi Y, Tokunaga O. Chlamydia pneumoniae and multiple infections in the aorta contribute to atherosclerosis. Pathol Int 2002; 52:755-63.
21. Shi Y, Tokunaga O. Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol Int 2002; 52:31-9.
22. Zanetti G, Baumgartner JD, Glauser MP. Sepsis and septic shock. Schweiz Med Wochenschr 1997; 127:489-99.
23. Talreja J, Kabir MH, M BF, Stechschulte DJ, Dileepan KN. Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components. Immunology 2004; 113:224-33.
24. 2 production in human coronary artery endothelial cells. J Immunol 2007; 179:7899-906.
25. Strakhova MI, Cuff CA, Manelli AM et al. In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory properties. Br J Pharmacol 2009; 157:44-54.
26. Kawamoto T, Ii M, Kitazaki T, Iizawa Y, Kimura H. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. Eur J Pharmacol 2008; 584:40-8.
27. Panaro MA, Gagliardi N, Saponaro C, Calvello R, Mitolo V, Cianciulli A. Toll-like receptor 4 mediates LPS-induced release of nitric oxide and tumor necrosis factor-alpha by embryonal cardiomyocytes: biological significance and clinical implications in human pathology. Curr Pharm Des 2010; 16:766-74.
28. Erridge C, Pridmore A, Eley A, Stewart J, Poxton IR. Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via toll-like receptor 2. J Med Microbiol 2004; 53:735-40.
29. Janssens S, Beyaert R. Role of Toll-like receptors in pathogen recognition. Clin Microbiol Rev 2003; 16:637-46.
30. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 2000; 165:618-22.
31. Balistreri CR, Candore G, Listi F et al. Role of TLR4 polymorphisms in inflammatory responses: implications for unsuccessful aging. Ann N Y Acad Sci 2007; 1119:203-7.
32. Candore G, Aquino A, Balistreri CR et al. Inflammation, longevity, and cardiovascular diseases: role of polymorphisms of TLR4. Ann N Y Acad Sci 2006; 1067:282-7.
33. Feng X, Zhang Y, Xu R, et al. Lipopolysaccharide up-regulates the expression of Fcalpha/mu receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody complex to activated human macrophages. Atherosclerosis 2010; 208: 396-405.
34. Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004; 16:3-9.
35. Takeuchi O, Akira S. Toll-like receptors; their physiological role and signal transduction system. Int Immunopharmacol 2001; 1:625-35.
36. Hao F, Tan M, Xu X, Cui MZ. Histamine induces Egr-1 expression in human aortic endothelial cells via the H1 receptor-mediated protein kinase Cdelta-dependent ERK activation pathway. J Biol Chem 2008; 283:26928-36.
37. Tanimoto A, Sasaguri Y, Ohtsu H. Histamine network in atherosclerosis. Trends Cardiovasc Med 2006; 16:280-4.
38. Muzio M, Polentarutti N, Bosisio D, Manoj Kumar PP, Mantovani A. Toll-like receptor family and signalling pathway. Biochem Soc Trans 2000; 28:563-6.
39. Oude Nijhuis MM, van Keulen JK, Pasterkamp G, Quax PH, de Kleijn DP. Activation of the innate immune system in atherosclerotic disease. Curr Pharm Des 2007; 13:983-94.
40. Shuang C, Wong MH, Schulte DJ, Arditi M, Michelsen KS. Differential expression of Toll-like receptor 2 (TLR2) and responses to TLR2 ligands between human and murine vascular endothelial cells. J Endotoxin Res 2007; 13:281-96.
41. Dunzendorfer S, Lee HK, Soldau K, Tobias PS. Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses. FASEB J 2004; 18:1117-9.
42. Jeziorska M, McCollum C, Woolley DE. Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries. J Pathol 1997; 182:115-22.
43. Jutel M, Blaser K, Akdis CA. The role of histamine in regulation of immune responses. Chem Immunol Allergy 2006; 91:174-87.
44. Sasaguri Y, Tanimoto A. Role of macrophage-derived histamine in atherosclerosis - chronic participation in the inflammatory response. J Atheroscler Thromb 2004; 11:122-30.
45. Sasaguri Y, Wang KY, Tanimoto A et al. Role of histamine produced by bone marrow-derived vascular cells in pathogenesis of atherosclerosis. Circ Res 2005; 96:974-81.
46. Iniguez MA, Cacheiro-Llaguno C, Cuesta N, Diaz-Munoz MD, Fresno M. Prostanoid function and cardiovascular disease. Arch Physiol Biochem 2008; 114:201-9.
47. Chi L, Li Y, Morrison DC, Stechschulte DJ, Dileepan KN. Production of IL-6 and IL-8 by endothelial cells through protease activated receptor stimulation. FASEB J 1999; 13:A1147-A.
48. Talreja J, Stechschulte DJ, Dileepan KN. Thrombin induces Toll-like receptor-2 (TLR2) and TLR4 expression and amplifies inflammatory responses to bacterial cell wall components in human coronary artery endothelial cells (HCAEC). FASEB J 2005; 19:A334-A.
49. Hirasawa N, Torigoe M, Kano K, Ohuchi K. Involvement of Sp1 in lipopolysaccharide-induced expression of HDC mRNA in RAW 264 cells. Biochem Biophys Res Commun 2006; 349:833-7.
50. Oguri S, Motegi K, Endo Y. Augmented lipopolysaccharide-induction of the histamine-forming enzyme in streptozotocin-induced diabetic mice. Biochim Biophys Acta 2003; 1637:83-90.
51. Wu X, Yoshida A, Sasano T, Iwakura Y, Endo Y. Histamine production via mast cell-independent induction of histidine decarboxylase in response to lipopolysaccharide and interleukin-1. Int Immunopharmacol 2004; 4:513-20.
52. Shoji N, Yoshida A, Yu Z, Endo Y, Sasano T. Lipopolysaccharide stimulates histamine-forming enzyme (histidine decarboxylase) activity in murine dental pulp and gingiva. Arch Oral Biol 2006; 51:856-60.
53. Smith TF, Aelvoet M, Morrison DC. The effect of bacterial lipopolysaccharide (LPS) on histamine release from human basophils. I. Enhancement of immunologic release by LPS. Clin Immunol Immunopathol 1985; 34:355-65.